All questions
Guidelines: Shingrix (Zoster Vaccine Recombinant, Adjuvanted) in herpes zoster prevention
4 questions · 2 sources
Guidelines questions that apply to every indication of Shingrix are on Shingrix (Zoster Vaccine Recombinant, Adjuvanted), all indications: Guidelines.
Guidelines
Does the CDC recommend Shingrix for adults 50 and older?
Applies to Prevention of herpes zoster (shingles) in adults aged 50 years and older
Note: The recommendation is as stated in the manufacturer's Shingles Vaccine Recommendations guide (dated April 2026), which cites the CDC shingles vaccine recommendations web page accessed May 31, 2025.
Does the CDC recommend Shingrix for immunocompromised adults 19 and older?
Applies to Prevention of herpes zoster (shingles) in adults aged 18 years and older who are or will be at increased risk of herpes zoster due to immunodeficiency or immunosuppression caused by known disease or therapy
Note: The CDC Recommendations page of the immunocompromised section of the Shingrix HCP site presents this recommendation under the heading "CDC Recommends:" and cites the 2022 ACIP recommendations (MMWR). The CDC recommendation covers adults 19 and older; the Prescribing Information indication covers adults 18 and older.
Shingrix and diabetes: what do ADA and AACE guidelines recommend?
Applies to Prevention of herpes zoster (shingles) in adults aged 50 years and older
Note: As presented in the manufacturer's Shingles Vaccine Recommendations guide (April 2026): the ADA statement concerns zoster vaccination and the AACE statement concerns recombinant zoster vaccine (RZV); the guide cites the ADA Standards of Care in Diabetes 2025 and the AACE 2022 clinical practice guideline.
Shingrix and COPD: what does the GOLD report recommend?
Applies to Prevention of herpes zoster (shingles) in adults aged 50 years and older
Note: As presented in the manufacturer's Shingles Vaccine Recommendations guide (April 2026): the GOLD statement concerns zoster vaccination in general; the guide cites the 2025 GOLD report.